Open AccessSwitching to nevirapine (NVP) significantly increases high‐density lipoprotein cholesterol (HDL‐C) in treatment‐experienced patients (NEVICOR study)
Author(s) -
Rodriguez JM,
Delgado M,
Viciana P,
LopezRuz MA,
Leal M,
Alcacer F,
Deig E,
Antela A,
Pedrol E,
Moreno S
Publication year - 2010
Publication title -
journal of the international aids society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.724
H-Index - 62
ISSN - 1758-2652
DOI - 10.1186/1758-2652-13-s4-p79
Subject(s) - medicine , nevirapine , efavirenz , abacavir , regimen , lamivudine , emtricitabine , gastroenterology , framingham risk score , pharmacotherapy , antiretroviral therapy , viral load , human immunodeficiency virus (hiv) , virology , disease , virus , hepatitis b virus
7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK